Intel Shares Drop 20 Percent as U.S. Government Holds Largest Investor Stake
Intel's reliance on federal investment ties the chipmaker's financial instability directly to taxpayer exposure, raising questions about the terms and oversight of that stake.
Intel Corporation's stock fell approximately 20 percent on October 29, 2026, after the company reported earnings showing that the artificial intelligence sector's growth had reduced demand for chips used in personal computers, according to reporting by The New York Times. The single most consequential element of that report for federal policy purposes: the U.S. Government is currently Intel's largest investor.
The Times report confirmed the government's investor status but did not specify the dollar value of that stake, the agency or fund through which it is held, or the terms under which it was acquired. The document that would answer those questions is the formal agreement between Intel and the relevant federal entity, likely structured under the CHIPS and Science Act of 2022, which authorized up to $52.7 billion in federal funding for domestic semiconductor manufacturing.
Congress passed the CHIPS and Science Act with bipartisan support. The Senate voted 64 to 33 in favor on July 27, 2022, and the House passed it 243 to 187 on July 28, 2022. President Biden signed the legislation on August 9, 2022. The law directed the Department of Commerce to administer direct funding awards and equity positions in recipient companies under specific conditions.
Intel was among the most prominent anticipated recipients of CHIPS Act funding. In March 2024, the Commerce Department announced a preliminary agreement to provide Intel with up to $8.5 billion in direct funding and up to $11 billion in loans, according to a Commerce Department press release at the time. That announcement did not, as of the time of publication, specify whether the agreement included an equity stake that would make the government Intel's largest shareholder.
If the government's position as largest investor reflects an equity stake taken as part of the CHIPS Act disbursement, the relevant governing document would be the final agreement between Intel and the Commerce Department, which would be subject to public disclosure requirements under federal procurement and grant law. As of publication, the final signed agreement has not been confirmed as publicly posted to USASpending.gov or the Commerce Department's CHIPS Program Office website.
The 20 percent single-day stock decline represents a meaningful reduction in the market value of any equity position the government holds. The exact dollar loss to the federal position cannot be calculated without knowing the number of shares held, the price at which they were acquired, and the terms governing when or whether the government may sell. None of those figures are confirmed in the Times report or in publicly available Commerce Department disclosures reviewed for this story.
Intel's reported difficulty stems from a specific market dynamic: companies that build personal computers have reduced chip orders because AI-optimized computing hardware has shifted customer and manufacturer spending away from traditional PC components. Intel has historically derived a large share of revenue from PC-related chip sales, a market segment that has contracted as enterprise and consumer spending increasingly flows toward AI-capable processors made by competitors including Nvidia and AMD.
The AI sector's effect on Intel is therefore a bifurcated one. AI growth has driven record revenues and stock valuations for chipmakers whose products are central to AI infrastructure, while simultaneously reducing demand for the type of chips Intel has long produced in the highest volume. Intel has announced plans to expand into AI chip manufacturing, in part using CHIPS Act funds, but those plans have not yet translated into revenue at a scale sufficient to offset PC-segment losses, based on the earnings report cited by the Times.
For Congress, the combination of federal equity exposure and a sharp stock decline is likely to prompt oversight activity, particularly from the House Committee on Science, Space, and Technology and the Senate Committee on Commerce, Science, and Transportation, both of which have jurisdiction over CHIPS Act implementation. Neither committee had scheduled a hearing on Intel's financial performance as of publication.
What remains unknown: the precise size and current market value of the government's Intel position, the agency or fund that holds it, the terms under which it may be liquidated, and whether any federal official with oversight responsibility has been formally notified of the earnings decline and its effect on the taxpayer-held stake. The Commerce Department's CHIPS Program Office and the Office of Management and Budget's federal investment disclosures would be the primary public records that could answer those questions.